01.03.2011 | Clinical Investigation
Ranibizumab treatment administered as needed for occult and minimally classic neovascular membranes in age-related macular degeneration
Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 2/2011
Einloggen, um Zugang zu erhalten